000			01208 a2200373 4500
005			20250511151745.0
264		0	_c19770129
008			197701s 0 0 eng d
022			_a0306-5251
040			_aNLM _beng _cNLM
100	1		_aKane, J
245	0	0	_aDouble-blind trial of labetalol. _h[electronic resource]
260			_bBritish journal of clinical pharmacology _cAug 1976
300			_a737-41 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aClinical Trials as Topic
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Evaluation
650	0	4	_aEthanolamines _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aHypertension _xdrug therapy
650	0	4	_aLabetalol _xadverse effects
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPulse _xdrug effects
650	0	4	_aTime Factors
700	1		_aGregg, I
700	1		_aRichards, D A
773	0		_tBritish journal of clinical pharmacology _gvol. 3 _gno. 4 Suppl 3 _gp. 737-41
999			_c802508 _d802508